We identified individuals whose serum contained a substance that produced falsely decreased thyroid hormone (T)-uptake values determined by the Emit" (Syva) procedure. Investigationof this interference was prompted by identification of a patient with T-uptake values inconsistent with clinical assessment. lgG depletion and supplementation studies with this patient's serum suggested that the interference was due to endogenous antibodies with specificityfor the thyroxine-glucose-6-phosphate dehydrogenase conjugate in the Emit T-uptake assay. The prevalence of the interference was examined by prospectively comparing routine Emit 1-uptake values of 1710 patients' samples to 1-uptake values obtained by another method. Discrepant samples were also assayed by a radioactive binding triiodothyronine-uptake assay. We identffied eight samples that had falsely decreased T-uptake values by Emit, for an overall prevalence of 0.46%. Among 45 consecutive patients with a T-uptake value <20%, five patients, or 11%, were falsely decreased by Emit and three of these were clearly due to an interfering lgG. We suggest that samples with abnormally low T-uptake values determined by the Emit method be confirmed by an alternative method.
IndexIngTerms: thyroid hormones/thyroid function/autoantibodles/immunoassays
Because concentrations of total thyroxine (T4) and its binding proteins can vary considerably, total T4 and its available protein binding sites (T-uptake) G-6-PDH activity was determined at room temperature by monitoring absorbance at 340 nm at 1-mm intervals for 15 mm as described (8).
MaterIals and Methods

Patients
Results and Discussion
In the same month, two patients were identified as having routinely reported T-uptake values (determined by Emit) that appeared extremely low for their clinical presentations.
An erroneous T-uptake result was suspected, and additional laboratory tests were performed. The T-uptake Emit assays were repeated and the values confirmed.
However, results of TSH, HA T3-uptake, total T4 by Emit and RIA, and calculated free T4 index by HA were within the reference ranges for both patients (Table 1 ). This suggested that there was a substance in these patients' samples that interfered with the Emit T-upt.ake method. Because we had previously identified endogenous antibodies that interfered with a T4 assay by another method (5), we investigated these sera for the presence of interfering antibodies.
After depletion of IgG by Protein A chromatography from patient A's serum, the T-uptake and free T4 index values by Emit were normal (Table 2) . Furthermore, when IgG of patient A was eluted from the Protein A column and added to a normal serum, the T-uptake value by Emit of this sample decreased from 29% to <15%. Sufficient sample was not available from patient B for similar experiments.
These results indicated that the IgG of patient A contained an antibody(s) that caused a marked negative interference in the Emit T-uptake method. In contrast to the interference observed in the Emit T-uptake assay, neither IgG depletion of serum from patient A nor addition of IgG from patient A to a normal serum significantly influenced the total T4 values by Emit (Table 2) . Because both Emit assays include the same T4-G-6-PDH conjugate, we speculate that the Emit T-uptake assay is more susceptible to this interference because: (a) the T-uptake assay ND., notdone.
requires fivefold more serum than the total T4 Emit assay; and (b) the T-uptake Emit method includes polyclonal anti-T4 antibodies, whereas the T4 Emit assay has a monoclonal anti-T4 antibody. Differences in the affinity of the anti-T4 reagents, along with different amounts of the T4-G-6-PDH conjugate in the two assays, may result in the T-uptake method being more prone to interference from endogenous antibodies. The effect of serum from patients A and B on the enzymatic activity of the T4-G-6-PDH conjugate of the Emit assay and native G-6-PDH was examined. Serum from patients A or B or from two control patients that exhibited no interference in the Emit T-uptake assay was incubated with T4-G-6-PDH label or with native G-6-PDH. Enzymatic activity of the T4-G-6-PDH was decreased by serum from patients A or B but not by the control sera (Table 3) . Interestingly, no decrease in enzymatic activity was observed when either serum from patients A or B or the control sera were incubated with native G-6-PDH (Table 3) . Furthermore, addition of excess T4 did not reverse the inhibition of T4-G-6-PDH activity induced by serum from patient A or B (Table 3) . These findings suggest that the interfering antibody(s) in the sera of patients A and B has specificity for the T4-G-6-PDH conjugate, but not for T4 or G-6-PDH alone.
To assess the clinical relevance and prevalence of this interference, we obtained HA T3-uptake and T4 RIA values for 45 consecutive patients with routine Emit T-uptake values <20%. Identification of these samples occurred over 11 weeks. In five of these patients with abnormally low T-uptake values by Emit, the HA T3-uptake was within the reference range (Fig. 1) . In four of these five patients the calculated free T4 index by Table 3 . InhibitIon of T4-G-6-PDH but not G-6-PDH by sera from patients A and B. 
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( In view of the high prevalence of this interference among patients selected for abnormally low T-uptake, we next determined the frequency of interfering antibodies in a general hospital patient population.
A total of 1710 routine samples were simultaneously analyzed by Emit (x) and Cedia (y) T-uptake assays over a period of 28 days. Regression analysis of values from the first 637 samples revealed: y = 1.02 x + 4.4, P <0.01, r = 0.89, S,.,, = 1.86, mean (y) = 34.0, mean (x) = 28.9 (Fig.  2) . Of these samples, 30 had Cedia T-uptake values 10% greater than Emit T-uptake values and were investigated further by analyzing with the HA T3-uptake. These 30 samples were identified on 16 different days and thus were not the result of one or two biased runs.
The HA T3-uptake values were equivocal for 22 of the 30 samples; none of these 22 had T-uptake or free T4 index values that placed them in different diagnostic categories by using the respective reference ranges.
Thus, differences
in Emit and Cedia T-upt.ake values for these 22 samples were likely due to random assay variability.
However, HA T3-uptake values supported the presence of a falsely low Emit T-uptake value for eight of these samples (Table 4 ). For six of the samples (patients C-H) the Cedia and Emit T-uptake values dilfered with respect to "normal" or "abnormal" categorization. In three of these patients (E, F, and H), clinical discrepancies were present in the T4 indices calculated with the different T-uptake values and may have resulted in diagnostic confusion. Two other samples (patients I and J) were not "clinically" discrepant but clearly exhibited a negative interference in the Emit T-uptake assay. After IgG depletion by Protein A chromatography, Emit T-uptake values increased to become consistent with the Cedia and HA T3-uptake values for six of the eight discrepant samples (Table 4) . However, the T-uptake results did not change in the other two samples (patients C and D). This demonstrates that the chromatography step itself does not affect the T-uptake values and also suggests that the interference observed in these latter patients may be due to IgG3, 1gM, or IgA that are not removed by Protein A.
Our studies clearly demonstrate that endogenous IgG can cause a negative interference in the Emit T-uptake assay. An overall incidence rate of 0.47% with falsely decreased T-uptake values by Emit when compared with two other T-uptake methods was found in our population. Emit T-uptake, % samples (of 1710) that had Cedia 1-uptake values 10% or more higher than Emit 1-uptake but did not exhibit a significant negative interference in the Emit method; A, eight samples (patients C-J) that had falsely low Emit 1-uptake values (see Table 4 ).
Emit was abnormally low, whereas the free T4 index by HA was normal. TSH values were normal or low in these five patients. In three of these five samples, the Emit T-uptake value returned to normal after Protein A depletion of IgG (Fig. 1) Table 4 . ThyroId function assays in eight patients with discrepant T-uptake results.
CLINICALCHEMISTRY,Vol. 40, No. 10, 1994 1943 that in "rare" instances individuals may have an interfering antibody, we feel the prevalence of this negative interference is sufficiently high that alternative T-uptake methods should be used before reporting an abnormally low T-upt.ake value determined by the Emit method.
Note added in proof:
The manufacturer has recently notified users that this interference occurs at a higher frequency than originally determined.
